Arkuda Therapeutics takes in $64m Series B
Arkuda Therapeutics, a biotechnology company, has raised $64 million in Series B financing.
Arkuda Therapeutics, a biotechnology company, has raised $64 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination